共 12 条
[1]
A multicenter phase Ⅱ trial of weekly irinotecan（CPT11） in patients with previously treated colorectal carcinoma. Rothenberg ML,Cox JV,DeVore RF,et al. Cancer . 1999
[2]
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Cunningham D,Pyrh nen S,James RD,et al. The Lancet . 1998
[3]
Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Rougier P,Cutsem EV,Bajetta E,et al. The Lancet . 1998
[4]
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Saltz LB,Cox JV,Blanke C,et al. The New England Journal of Medicine . 2000
[5]
Irinotecan combined with fluorouracil compared with fluorouracil alone as first_line treatment for metastatic colorectal cancer: a multicentre randomized trial. Douillard JY,Cunningham D,Roth AD,et al. The Lancet . 2000
[6]
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer:Results of a randomized phase Ⅱ study. Cutsem EV,Findlay M,Osterwalder B,et al. Journal of Clinical Oncology . 2000
[7]
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first_line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase Ⅲ study. Hoff PM,Ansari R,Batist G,et al. Journal of Clinical Oncology . 2001
[8]
Phase Ⅲ multicenter randomized trial of Oxaliplatin added to chronomodulated fluorouracil_leucovorin as first_line treatment of metastatic colorectal cancer. Giacchetti S,Perpoint B,Zidani R,et al. Journal of Clinical Oncology . 2000
[9]
Phase Ⅱstudy of S1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal cancer. Ohtsu A,Baba H,Sakata Y,et al. British Journal of Cancer . 2000
[10]
Randomized trial comparing monthly low_dose leucovorin and fluorouracil obolus plus continuous infusion for advanced coloaectal cancer: A French intergroup study. de Gramon A,Bosset J_F,Milan C,et al. Journal of Clinical Oncology . 1997